Global Biodefense Market Size, Status and Forecast 2020-2026


Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.
Market Analysis and Insights: Global Biodefense Market
In 2019, the global Biodefense market size was US$ 988.3 million and it is expected to reach US$ 1627.2 million by the end of 2026, with a CAGR of 7.3% during 2021-2026.
Global Biodefense Scope and Market Size
Biodefense market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biodefense market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Biodefense market is segmented into Anthrax, Smallpox, Botulism, Radiation/Nuclear, Others, etc.
Segment by Application, the Biodefense market is segmented into US Military Market, US Civilian Market, Non - US Market, etc.
Regional and Country-level Analysis
The Biodefense market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biodefense market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape and Biodefense Market Share Analysis
Biodefense market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Biodefense business, the date to enter into the Biodefense market, Biodefense product introduction, recent developments, etc.
The major vendors include Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma, DynPort Vaccine, Xoma Corporation, Ichor Medical Systems, Aeolus Pharmaceuticals, Achaogen, Elusys Therapeutics, Dynavax Technologies, Cleveland BioLabs, Soligenix, Alnylam Pharmaceuticals, etc.

This report focuses on the global Biodefense status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biodefense development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
    Emergent Biosolutions
    Hytest
    GSK
    Sanofi
    PharmAthene
    Bavarian Nordic
    SIGA Technologies
    Arbutus Biopharma
    DynPort Vaccine
    Xoma Corporation
    Ichor Medical Systems
    Aeolus Pharmaceuticals
    Achaogen
    Elusys Therapeutics
    Dynavax Technologies
    Cleveland BioLabs
    Soligenix
    Alnylam Pharmaceuticals

Market segment by Type, the product can be split into
    Anthrax
    Smallpox
    Botulism
    Radiation/Nuclear
    Others
Market segment by Application, split into
    US Military Market
    US Civilian Market
    Non - US Market

Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Biodefense status, future forecast, growth opportunity, key market and key players.
    To present the Biodefense development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Biodefense are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered: Ranking by Biodefense Revenue
    1.4 Market Analysis by Type
        1.4.1 Global Biodefense Market Size Growth Rate by Type: 2020 VS 2026
        1.4.2 Anthrax
        1.4.3 Smallpox
        1.4.4 Botulism
        1.4.5 Radiation/Nuclear
        1.4.6 Others
    1.5 Market by Application
        1.5.1 Global Biodefense Market Share by Application: 2020 VS 2026
        1.5.2 US Military Market
        1.5.3 US Civilian Market
        1.5.4 Non - US Market
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
    2.1 Biodefense Market Perspective (2015-2026)
    2.2 Biodefense Growth Trends by Regions
        2.2.1 Biodefense Market Size by Regions: 2015 VS 2020 VS 2026
        2.2.2 Biodefense Historic Market Share by Regions (2018-2019)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Competition Landscape by Key Players
    3.1 Biodefense Revenue by Players (2019-2020)
    3.2 Biodefense Key Players Head office and Area Served
    3.3 Key Players Biodefense Product/Solution/Service
    3.4 Date of Enter into Biodefense Market
    3.5 Key Players Biodefense Funding/Investment Analysis
    3.6 Global Key Players Biodefense Valuation & Market Capitalization
    3.7 Mergers & Acquisitions, Expansion Plans

    4.2 Global Biodefense Forecasted Market Size by Type (2021-2026)

    5.2 Global Biodefense Forecasted Market Size by Application (2021-2026)
    4 Global Biodefense Market Size by Type (2019-2026)
    5 Global Biodefense Market Size by Application (2019-2026)

6 North America
    6.1 North America Biodefense Market Forecast (2019-2026)
    6.2 Biodefense Key Players in North America (2019-2020)
    6.3 North America Biodefense Market Size by Type (2015-2020)
    6.4 North America Biodefense Market Size by Application (2015-2020)

7 Europe
    7.1 Europe Biodefense Market Forecast (2019-2026)
    7.2 Biodefense Key Players in Europe (2019-2020)
    7.3 Europe Biodefense Market Size by Type (2015-2020)
    7.4 Europe Biodefense Market Size by Application (2015-2020)

8 China
    8.1 China Biodefense Market Forecast (2019-2026)
    8.2 Biodefense Key Players in China (2019-2020)
    8.3 China Biodefense Market Size by Type (2015-2020)
    8.4 China Biodefense Market Size by Application (2015-2020)

9 Japan
    9.1 Japan Biodefense Market Forecast (2019-2026)
    9.2 Biodefense Key Players in Japan (2019-2020)
    9.3 Japan Biodefense Market Size by Type (2015-2020)
    9.4 Japan Biodefense Market Size by Application (2015-2020)

10 Southeast Asia
    10.1 Southeast Asia Biodefense Market Forecast (2019-2026)
    10.2 Biodefense Key Players in Southeast Asia (2019-2020)
    10.3 Southeast Asia Biodefense Market Size by Type (2015-2020)
    10.4 Southeast Asia Biodefense Market Size by Application (2015-2020)

11 India
    11.1 India Biodefense Market Forecast (2019-2026)
    11.2 Biodefense Key Players in India (2019-2020)
    11.3 India Biodefense Market Size by Type (2015-2020)
    11.4 India Biodefense Market Size by Application (2015-2020)

12 Central & South America
    12.1 Central & South America Biodefense Market Forecast (2019-2026)
    12.2 Biodefense Key Players in Central & South America (2019-2020)
    12.3 Central & South America Biodefense Market Size by Type (2015-2020)
    12.4 Central & South America Biodefense Market Size by Application (2015-2020)

13Key Players Profiles
    13.1 Emergent Biosolutions
        13.1.1 Emergent Biosolutions Company Details
        13.1.2 Emergent Biosolutions Business Overview and Its Total Revenue
        13.1.3 Emergent Biosolutions Biodefense Introduction
        13.1.4 Emergent Biosolutions Revenue in Biodefense Business (2019-2020))
        13.1.5 Emergent Biosolutions Recent Development
    13.2 Hytest
        13.2.1 Hytest Company Details
        13.2.2 Hytest Business Overview and Its Total Revenue
        13.2.3 Hytest Biodefense Introduction
        13.2.4 Hytest Revenue in Biodefense Business (2019-2020))
        13.2.5 Hytest Recent Development
    13.3 GSK
        13.3.1 GSK Company Details
        13.3.2 GSK Business Overview and Its Total Revenue
        13.3.3 GSK Biodefense Introduction
        13.3.4 GSK Revenue in Biodefense Business (2019-2020))
        13.3.5 GSK Recent Development
    13.4 Sanofi
        13.4.1 Sanofi Company Details
        13.4.2 Sanofi Business Overview and Its Total Revenue
        13.4.3 Sanofi Biodefense Introduction
        13.4.4 Sanofi Revenue in Biodefense Business (2019-2020))
        13.4.5 Sanofi Recent Development
    13.5 PharmAthene
        13.5.1 PharmAthene Company Details
        13.5.2 PharmAthene Business Overview and Its Total Revenue
        13.5.3 PharmAthene Biodefense Introduction
        13.5.4 PharmAthene Revenue in Biodefense Business (2019-2020))
        13.5.5 PharmAthene Recent Development
    13.6 Bavarian Nordic
        13.6.1 Bavarian Nordic Company Details
        13.6.2 Bavarian Nordic Business Overview and Its Total Revenue
        13.6.3 Bavarian Nordic Biodefense Introduction
        13.6.4 Bavarian Nordic Revenue in Biodefense Business (2019-2020))
        13.6.5 Bavarian Nordic Recent Development
    13.7 SIGA Technologies
        13.7.1 SIGA Technologies Company Details
        13.7.2 SIGA Technologies Business Overview and Its Total Revenue
        13.7.3 SIGA Technologies Biodefense Introduction
        13.7.4 SIGA Technologies Revenue in Biodefense Business (2019-2020))
        13.7.5 SIGA Technologies Recent Development
    13.8 Arbutus Biopharma
        13.8.1 Arbutus Biopharma Company Details
        13.8.2 Arbutus Biopharma Business Overview and Its Total Revenue
        13.8.3 Arbutus Biopharma Biodefense Introduction
        13.8.4 Arbutus Biopharma Revenue in Biodefense Business (2019-2020))
        13.8.5 Arbutus Biopharma Recent Development
    13.9 DynPort Vaccine
        13.9.1 DynPort Vaccine Company Details
        13.9.2 DynPort Vaccine Business Overview and Its Total Revenue
        13.9.3 DynPort Vaccine Biodefense Introduction
        13.9.4 DynPort Vaccine Revenue in Biodefense Business (2019-2020))
        13.9.5 DynPort Vaccine Recent Development
    13.10 Xoma Corporation
        13.10.1 Xoma Corporation Company Details
        13.10.2 Xoma Corporation Business Overview and Its Total Revenue
        13.10.3 Xoma Corporation Biodefense Introduction
        13.10.4 Xoma Corporation Revenue in Biodefense Business (2019-2020))
        13.10.5 Xoma Corporation Recent Development
    13.11 Ichor Medical Systems
        10.11.1 Ichor Medical Systems Company Details
        10.11.2 Ichor Medical Systems Business Overview and Its Total Revenue
        10.11.3 Ichor Medical Systems Biodefense Introduction
        10.11.4 Ichor Medical Systems Revenue in Biodefense Business (2019-2020))
        10.11.5 Ichor Medical Systems Recent Development
    13.12 Aeolus Pharmaceuticals
        10.12.1 Aeolus Pharmaceuticals Company Details
        10.12.2 Aeolus Pharmaceuticals Business Overview and Its Total Revenue
        10.12.3 Aeolus Pharmaceuticals Biodefense Introduction
        10.12.4 Aeolus Pharmaceuticals Revenue in Biodefense Business (2019-2020))
        10.12.5 Aeolus Pharmaceuticals Recent Development
    13.13 Achaogen
        10.13.1 Achaogen Company Details
        10.13.2 Achaogen Business Overview and Its Total Revenue
        10.13.3 Achaogen Biodefense Introduction
        10.13.4 Achaogen Revenue in Biodefense Business (2019-2020))
        10.13.5 Achaogen Recent Development
    13.14 Elusys Therapeutics
        10.14.1 Elusys Therapeutics Company Details
        10.14.2 Elusys Therapeutics Business Overview and Its Total Revenue
        10.14.3 Elusys Therapeutics Biodefense Introduction
        10.14.4 Elusys Therapeutics Revenue in Biodefense Business (2019-2020))
        10.14.5 Elusys Therapeutics Recent Development
    13.15 Dynavax Technologies
        10.15.1 Dynavax Technologies Company Details
        10.15.2 Dynavax Technologies Business Overview and Its Total Revenue
        10.15.3 Dynavax Technologies Biodefense Introduction
        10.15.4 Dynavax Technologies Revenue in Biodefense Business (2019-2020))
        10.15.5 Dynavax Technologies Recent Development
    13.16 Cleveland BioLabs
        10.16.1 Cleveland BioLabs Company Details
        10.16.2 Cleveland BioLabs Business Overview and Its Total Revenue
        10.16.3 Cleveland BioLabs Biodefense Introduction
        10.16.4 Cleveland BioLabs Revenue in Biodefense Business (2019-2020))
        10.16.5 Cleveland BioLabs Recent Development
    13.17 Soligenix
        10.17.1 Soligenix Company Details
        10.17.2 Soligenix Business Overview and Its Total Revenue
        10.17.3 Soligenix Biodefense Introduction
        10.17.4 Soligenix Revenue in Biodefense Business (2019-2020))
        10.17.5 Soligenix Recent Development
    13.18 Alnylam Pharmaceuticals
        10.18.1 Alnylam Pharmaceuticals Company Details
        10.18.2 Alnylam Pharmaceuticals Business Overview and Its Total Revenue
        10.18.3 Alnylam Pharmaceuticals Biodefense Introduction
        10.18.4 Alnylam Pharmaceuticals Revenue in Biodefense Business (2019-2020))
        10.18.5 Alnylam Pharmaceuticals Recent Development

14 Market Dynamics
    14.1 Drivers
    14.2 Challenges
    14.3 Porter’s Five Forces Analysis
    14.4 Market Ecosystem and Value Chain Analysis

15 Key Findings in This Report
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Disclaimer
    15.3 Author Details

List of Tables Table 1. Biodefense Key Market Segments Table 2. Key Players Covered: Ranking by Biodefense Revenue Table 3. Ranking of Global Top Biodefense Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Biodefense Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Anthrax Table 6. Key Players of Smallpox Table 7. Key Players of Botulism Table 8. Key Players of Radiation/Nuclear Table 9. Key Players of Others Table 10. Global Biodefense Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global Biodefense Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global Biodefense Market Size by Regions (US$ Million): 2020 VS 2026 Table 13. Global Biodefense Market Share by Regions 2019-2026 Table 14. Market Top Trends Table 15. Market Use Cases Table 16. Global Biodefense Revenue by Players (2019-2020) (Million US$) Table 17. Global Biodefense Market Share by Players (2019-2020) Table 18. Key Players Headquarters and Area Served Table 19. Key Players Biodefense Product Solution and Service Table 20. Date of Enter into Biodefense Market Table 21. Global Key Players Biodefense Funding/Investment Analysis (Million USD) Table 22. Global Key Players Biodefense Valuation & Market Capitalization (Million USD) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Biodefense Market Size by Type (2019-2026) (Million US$) Table 25. Global Biodefense Market Size Share by Type (2019-2026) Table 26. Global Biodefense Market Size by Application (2019-2026) (Million US$) Table 27. Global Biodefense Market Size Share by Application (2019-2026) Table 28. North America Key Players Biodefense Revenue (2019-2020) (Million US$) Table 29. North America Key Players Biodefense Market Share (2019-2020) Table 30. North America Biodefense Market Size by Type (2019-2026) (Million US$) Table 31. North America Biodefense Market Share by Type (2019-2026) Table 32. North America Biodefense Market Size by Application (2019-2026) (Million US$) Table 33. North America Biodefense Market Share by Application (2019-2026) Table 34. Europe Key Players Biodefense Revenue (2019-2020) (Million US$) Table 35. Europe Key Players Biodefense Market Share (2019-2020) Table 36. Europe Biodefense Market Size by Type (2019-2026) (Million US$) Table 37. Europe Biodefense Market Share by Type (2019-2026) Table 38. Europe Biodefense Market Size by Application (2019-2026) (Million US$) Table 39. Europe Biodefense Market Share by Application (2019-2026) Table 40. China Key Players Biodefense Revenue (2019-2020) (Million US$) Table 41. China Key Players Biodefense Market Share (2019-2020) Table 42. China Biodefense Market Size by Type (2019-2026) (Million US$) Table 43. China Biodefense Market Share by Type (2019-2026) Table 44. China Biodefense Market Size by Application (2019-2026) (Million US$) Table 45. China Biodefense Market Share by Application (2019-2026) Table 46. Japan Key Players Biodefense Revenue (2019-2020) (Million US$) Table 47. Japan Key Players Biodefense Market Share (2019-2020) Table 48. Japan Biodefense Market Size by Type (2019-2026) (Million US$) Table 49. Japan Biodefense Market Share by Type (2019-2026) Table 50. Japan Biodefense Market Size by Application (2019-2026) (Million US$) Table 51. Japan Biodefense Market Share by Application (2019-2026) Table 52. Southeast Asia Key Players Biodefense Revenue (2019-2020) (Million US$) Table 53. Southeast Asia Key Players Biodefense Market Share (2019-2020) Table 54. Southeast Asia Biodefense Market Size by Type (2019-2026) (Million US$) Table 55. Southeast Asia Biodefense Market Share by Type (2019-2026) Table 56. Southeast Asia Biodefense Market Size by Application (2019-2026) (Million US$) Table 57. Southeast Asia Biodefense Market Share by Application (2019-2026) Table 58. India Key Players Biodefense Revenue (2019-2020) (Million US$) Table 59. India Key Players Biodefense Market Share (2019-2020) Table 60. India Biodefense Market Size by Type (2019-2026) (Million US$) Table 61. India Biodefense Market Share by Type (2019-2026) Table 62. India Biodefense Market Size by Application (2019-2026) (Million US$) Table 63. India Biodefense Market Share by Application (2019-2026) Table 64. Central & South America Key Players Biodefense Revenue (2019-2020) (Million US$) Table 65. Central & South America Key Players Biodefense Market Share (2019-2020) Table 66. Central & South America Biodefense Market Size by Type (2019-2026) (Million US$) Table 67. Central & South America Biodefense Market Share by Type (2019-2026) Table 68. Central & South America Biodefense Market Size by Application (2019-2026) (Million US$) Table 69. Central & South America Biodefense Market Share by Application (2019-2026) Table 70. Emergent Biosolutions Company Details Table 71. Emergent Biosolutions Business Overview Table 72. Emergent Biosolutions Product Table 73. Company Description and Business Overview Table 74. Emergent Biosolutions Biodefense Product Table 75. Emergent Biosolutions Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 76. Emergent Biosolutions Recent Development Table 77. Hytest Company Details Table 78. Hytest Business Overview Table 79. Hytest Product Table 80. Company Description and Business Overview Table 81. Hytest Biodefense Product Table 82. Hytest Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 83. Hytest Recent Development Table 84. GSK Company Details Table 85. GSK Business Overview Table 86. GSK Product Table 87. Company Description and Business Overview Table 88. GSK Biodefense Product Table 89. GSK Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 90. GSK Recent Development Table 91. Sanofi Company Details Table 92. Sanofi Business Overview Table 93. Sanofi Product Table 94. Company Description and Business Overview Table 95. Sanofi Biodefense Product Table 96. Sanofi Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 97. Sanofi Recent Development Table 98. PharmAthene Company Details Table 99. PharmAthene Business Overview Table 100. PharmAthene Product Table 101. Company Description and Business Overview Table 102. PharmAthene Biodefense Product Table 103. PharmAthene Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 104. PharmAthene Recent Development Table 105. Bavarian Nordic Company Details Table 106. Bavarian Nordic Business Overview Table 107. Bavarian Nordic Product Table 108. Company Description and Business Overview Table 109. Bavarian Nordic Biodefense Product Table 110. Bavarian Nordic Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 111. Bavarian Nordic Recent Development Table 112. SIGA Technologies Company Details Table 113. SIGA Technologies Business Overview Table 114. SIGA Technologies Product Table 115. Company Description and Business Overview Table 116. SIGA Technologies Biodefense Product Table 117. SIGA Technologies Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 118. SIGA Technologies Recent Development Table 119. Arbutus Biopharma Business Overview Table 120. Arbutus Biopharma Product Table 121. Arbutus Biopharma Company Details Table 122. Company Description and Business Overview Table 123. Arbutus Biopharma Biodefense Product Table 124. Arbutus Biopharma Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 125. Arbutus Biopharma Recent Development Table 126. DynPort Vaccine Company Details Table 127. DynPort Vaccine Business Overview Table 128. DynPort Vaccine Product Table 129. Company Description and Business Overview Table 130. DynPort Vaccine Biodefense Product Table 131. DynPort Vaccine Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 132. DynPort Vaccine Recent Development Table 133. Xoma Corporation Company Details Table 134. Xoma Corporation Business Overview Table 135. Xoma Corporation Product Table 136. Company Description and Business Overview Table 137. Xoma Corporation Biodefense Product Table 138. Xoma Corporation Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 139. Xoma Corporation Recent Development Table 140. Ichor Medical Systems Company Details Table 141. Ichor Medical Systems Business Overview Table 142. Ichor Medical Systems Product Table 143. Company Description and Business Overview Table 144. Ichor Medical Systems Biodefense Product Table 145. Ichor Medical Systems Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 146. Ichor Medical Systems Recent Development Table 147. Aeolus Pharmaceuticals Company Details Table 148. Aeolus Pharmaceuticals Business Overview Table 149. Aeolus Pharmaceuticals Product Table 150. Company Description and Business Overview Table 151. Aeolus Pharmaceuticals Biodefense Product Table 152. Aeolus Pharmaceuticals Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 153. Aeolus Pharmaceuticals Recent Development Table 154. Achaogen Company Details Table 155. Achaogen Business Overview Table 156. Achaogen Product Table 157. Company Description and Business Overview Table 158. Achaogen Biodefense Product Table 159. Achaogen Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 160. Achaogen Recent Development Table 161. Elusys Therapeutics Company Details Table 162. Elusys Therapeutics Business Overview Table 163. Elusys Therapeutics Product Table 164. Company Description and Business Overview Table 165. Elusys Therapeutics Biodefense Product Table 166. Elusys Therapeutics Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 167. Elusys Therapeutics Recent Development Table 168. Dynavax Technologies Company Details Table 169. Dynavax Technologies Business Overview Table 170. Dynavax Technologies Product Table 171. Company Description and Business Overview Table 172. Dynavax Technologies Biodefense Product Table 173. Dynavax Technologies Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 174. Dynavax Technologies Recent Development Table 175. Cleveland BioLabs Company Details Table 176. Cleveland BioLabs Business Overview Table 177. Cleveland BioLabs Product Table 178. Company Description and Business Overview Table 179. Cleveland BioLabs Biodefense Product Table 180. Cleveland BioLabs Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 181. Cleveland BioLabs Recent Development Table 182. Soligenix Company Details Table 183. Soligenix Business Overview Table 184. Soligenix Product Table 185. Company Description and Business Overview Table 186. Soligenix Biodefense Product Table 187. Soligenix Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 188. Soligenix Recent Development Table 189. Alnylam Pharmaceuticals Company Details Table 190. Alnylam Pharmaceuticals Business Overview Table 191. Alnylam Pharmaceuticals Product Table 192. Company Description and Business Overview Table 193. Alnylam Pharmaceuticals Biodefense Product Table 194. Alnylam Pharmaceuticals Revenue in Biodefense Business 2019 and 2020 (Million US$) Table 195. Alnylam Pharmaceuticals Recent Development Table 196. Company Description and Business Overview Table 197. Company Description and Business Overview Table 198. Company Description and Business Overview Table 199. Company Description and Business Overview Table 200. Company Description and Business Overview Table 201. Company Description and Business Overview Table 202. Company Description and Business Overview Table 203. Company Description and Business Overview Table 204. Company Description and Business Overview Table 205. Company Description and Business Overview Table 206. Company Description and Business Overview Table 207. Company Description and Business Overview Table 208. Company Description and Business Overview Table 209. Company Description and Business Overview Table 210. Company Description and Business Overview Table 211. Company Description and Business Overview Table 212. Company Description and Business Overview Table 213. Company Description and Business Overview Table 214. Company Description and Business Overview Table 215. Company Description and Business Overview Table 216. Company Description and Business Overview Table 217. Company Description and Business Overview Table 218. Key Drivers: Impact Analysis (2021-2026) Table 219. Key Opportunities Table 220. Key Challenges Table 221. Research Programs/Design for This Report Table 222. Key Data Information from Secondary Sources Table 223. Key Data Information from Primary Sources List of Figures Figure 1. Global Biodefense Market Share by Type: 2020 VS 2026 Figure 2. Anthrax Features Figure 3. Smallpox Features Figure 4. Botulism Features Figure 5. Radiation/Nuclear Features Figure 6. Others Features Figure 7. Global Biodefense Market Share by Application: 2020 VS 2026 Figure 8. US Military Market Case Studies Figure 9. US Civilian Market Case Studies Figure 10. Non - US Market Case Studies Figure 11. Biodefense Report Years Considered Figure 12. Global Biodefense and Growth Rate (2019-2026) (Million US$) Figure 13. Global Biodefense Market Share by Regions (2019-2026) Figure 14. Global Biodefense Market Share by Players in 2019 Figure 15. Global Biodefense Market Size Market Share by Type (2019-2026) Figure 16. Global Biodefense Market Size Market Share by Application (2019-2026) Figure 17. North America Biodefense Market Size YoY Growth (2019-2026) (Million US$) Figure 18. Europe Biodefense Market Size YoY Growth (2019-2026) (Million US$) Figure 19. China Biodefense Market Size YoY Growth (2019-2026) (Million US$) Figure 20. Japan Biodefense Market Size YoY Growth (2019-2026) (Million US$) Figure 21. Southeast Asia Biodefense Market Size YoY Growth (2019-2026) (Million US$) Figure 22. India Biodefense Market Size YoY Growth (2019-2026) (Million US$) Figure 23. Central & South America Biodefense Market Size YoY Growth (2019-2026) (Million US$) Figure 24. Bottom-up and Top-down Approaches for This Report Figure 25. Data Triangulation Figure 26. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global CSP NFV Management and Orchestration Solutions Market Size, Status and Forecast 2020-2026

This report focuses on the global CSP NFV Management and Orchestration Solutions status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CSP NFV Management and Orchestration Solutions developme...

Global Crowdsourced Application Testing Services Market Size, Status and Forecast 2020-2026

This report focuses on the global Crowdsourced Application Testing Services status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Crowdsourced Application Testing Services development in Nort...

Global CRM and Customer Experience Implementation Services Market Size, Status and Forecast 2020-2026

This report focuses on the global CRM and Customer Experience Implementation Services status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CRM and Customer Experience Implementation Services...

Global Content Collaboration Platforms (CCP) Market Size, Status and Forecast 2020-2026

This report focuses on the global Content Collaboration Platforms (CCP) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Content Collaboration Platforms (CCP) development in North Americ...

Global Configure, Price and Quote Application Suites Market Size, Status and Forecast 2020-2026

This report focuses on the global Configure, Price and Quote Application Suites status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Configure, Price and Quote Application Suites development...

New Media and Technology Reports

Publisher: QY Research